Tuesday, October 8, 2013

Alfred Mann Keynotes 2014 DDP: Driving True Drug Delivery Innovation

IIR’s 18th Annual Drug Delivery Partnerships event, provides you with an incomparable opportunity to hear from some of the industry's leaders...Alfred Mann, Chief Executive Officer and Chairman of the Board for the MannKind Corporation has been confirmed as the DDP 2014 Keynote Innovator!

Mr. Mann and his colleague, Andrea Leone-Bay, the Vice President of Pharmaceutical Development will be presenting a two-part talk beginning with Mr. Mann's insight on "Driving Innovation in Drug Delivery by Meeting the Unmet Need," and Andrea Leone-Bay following with discussion of MannKind's ground-breaking Oral Inhalation product.

The drug delivery industry was abuzz when MannKind announced positive clinical data for AFREZZA; a novel, ultra rapid-acting mealtime insulin therapy for the treatment of adult patients with type 1 or type 2 diabetes for the control of hyperglycemia. It is a drug-device combination product, consisting of AFREZZA Inhalation Powder, pre-metered into single-use cartridges, and a light, discreet and easy-to-use inhaler.

Driving True Innovation in Drug Delivery by Defining and Meeting the Unmet Need:

• The long road to developing an inhaled insulin product
• Advice to the innovator for creating a unique and commercially successful product
• Examining how industry trends have shaped the drug delivery landscape and what we can learn from these trends moving forward

Speaker: Alfred Mann, Chief Executive Officer, Chairman of the Board, MannKind Corporation

Advantages of Simple, Patient-Friendly Drug Delivery by Oral Inhalation for the Development of New Drugs and for Life-Cycle Management of Established Drugs:

Drug delivery by oral inhalation is standard for the treatment of pulmonary disease. The development of a simplified, cost-effective oral inhalation system that allows patients to self-administer medicines using simple, breath-powered devices now opens this route of administration to a wide variety of indications. This approach can be used with new therapies to gain competitive advantage and can breathe new life into "old" drugs. Case studies for diabetes, pain, and pulmonary disease will be presented

Speaker: Andrea Leone-Bay, Vice President, Pharmaceutical Development, MannKind Corporation

To learn more, download the agenda.

Use priority code XP1978BLOG to register and save 15% off of the standard rate. If you have any questions about the agenda or event, please contact Kate Devery at kdevery@iirusa.com or visit our webpage. We look forward to seeing January 27-29 in Boca Raton FL!

The Drug Delivery Partnerships International Team

The DDP Homepage
DDP Twitter
Join our DDP LinkedIn Group

No comments:

Post a Comment